The validity period for the approval for 30 active substances has been extended by one year due to the delay in the re-evaluation following the application for renewal of the approval. If the review for any of the active ingredients leads to rejection of the renewal application in the meantime, the approval will expire with a corresponding order ahead of schedule.
We list the chemical active ingredients only.
The following active substances were extended by one year:
Active Ingredients |
Limited until |
Reference |
Abamectin |
04/30/2023 |
COMMISSION IMPLEMENTING REGULATION (EU) 2022/378 of 4 March 20221) |
Clodinafop |
||
Cyprodinil |
||
Dichlorprop-P |
||
Fenpyroximate |
||
Fosetyl |
||
Malathion |
||
Mepanipyrim |
||
Metconazole |
||
Metrafenone |
||
Pirimicarb |
||
Pyrimethanil |
||
Rimsulfuron |
||
Spinosad |
||
Triclopyr |
||
Trinexapac |
||
Triticonazole |
||
Ziram |
The lifetime extensions have no influence on the current maximum residue limits.
Link:
Author: Frank Mörsberger